Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

  • Home
  • Audit Findings
    • General Audit Findings in Clinical Trials
    • Investigator Site-Level Audit Findings
    • Sponsor & CRO-Level Audit Findings
    • Trial Master File (TMF) & eTMF Audit Findings
    • Informed Consent Audit Findings
    • Safety Reporting Audit Findings
    • Data Integrity & EDC Audit Findings
    • GCP Training & Compliance Audit Findings
    • Clinical Trial Supply & IMP Audit Findings
    • Ethics Committee / IRB Audit Findings
    • CAPA & Inspection Readiness Audit Findings
    • Case Studies & Trends in Audit Findings
  • Audits, CAPA & Deviations
    • CRO Audit Oversight
    • CAPA Management in CROs
    • Deviation Handling in CROs
    • Inspection Readiness for CROs
    • Data Integrity & Systems Oversight
    • Training & Quality Culture in CROs
  • SOPs for GCP
    • Global SOPs (Applicable to all Agencies)
    • SOP for IDE/Device
    • FDA — Unique SOPs (United States)
    • EMA — Unique SOPs (European Union)
    • CDSCO/DCGI – Unique SOPs (India)
    • WHO – Unique SOPs
    • ICH – Unique SOPs
    • MHRA — Unique SOPs (United Kingdom)
    • Health Canada — Unique SOPs (Canada)
    • PMDA — Unique SOPs
    • TGA — Unique SOPs
    • NMPA — Unique SOPs
    • ANVISA — Unique SOPs
    • Swiss Medic — Unique SOPs
    • Medsafe/HDEC — Unique SOPs (New Zealand)
  • US Regulatory Submissions
  • Toggle search form

SOP for Multilingual Documentation and Country Retention Rules

Posted on August 30, 2025 digi By digi

SOP for Multilingual Documentation and Country Retention Rules

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-country-retention-rules”
},
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-country-retention-rules”,
“headline”: “SOP for Multilingual Documentation and Country Retention Rules”,
“name”: “SOP for Multilingual Documentation and Country Retention Rules”,
“description”: “Comprehensive SOP describing sponsor and investigator responsibilities for multilingual documentation preparation and adherence to Swiss country-specific retention requirements for clinical trials.”,
“keywords”: “multilingual documentation SOP Switzerland, Swiss trial document retention SOP, SOP for clinical trial translation Switzerland, SOP for document localization Switzerland, SOP for archiving Swiss trial documents, SOP for multilingual ICFs Switzerland, SOP for sponsor responsibilities Swiss documentation, SOP for BASEC submission multilingual documents, SOP for retention ClinO Switzerland, SOP for inspection readiness Switzerland, SOP for record keeping SOP Switzerland, SOP for document governance Switzerland, SOP for regulatory submissions multilingual Switzerland, SOP for language compliance Swiss clinical trials, SOP for document archival retention Switzerland, SOP for clinical trial document translation QA, SOP for bilingual Swiss trial governance, SOP for translation vendor management Switzerland, SOP for document authenticity Switzerland, SOP for sponsor-site responsibilities Switzerland,

SOP for TMF retention Switzerland, SOP for ISF retention Switzerland, SOP for GCP compliance Switzerland, SOP for ethics submission multilingual Switzerland, SOP for patient document translation Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

See also  SOP for Re-consent Procedures

Published on 21/12/2025

Multilingual Documentation and Country Retention Rules SOP

Department Clinical Research
SOP No. CS/SWISS-DOC/191/2025
Supersedes N.A.
Page No. 1 of 22
Issue Date 28/08/2025
Effective Date 05/09/2025
Review Date 05/09/2027

Table of Contents

Toggle
  • Purpose
  • Scope
  • Responsibilities
  • Accountability
  • Procedure
  • Abbreviations
  • Documents
  • References
  • Approval
  • Annexures
  • Revision History

Purpose

This SOP defines the process for preparing multilingual documentation and complying with Switzerland’s specific retention rules for clinical trial documentation. It ensures that subject-facing documents and regulatory submissions are linguistically and legally compliant under Swissmedic and BASEC requirements.

Scope

This SOP applies to all clinical trials conducted in Switzerland, covering translation, back-translation, certification, and retention of essential trial documents including informed consent forms, patient information sheets, investigator brochures, protocols, and safety reports. It applies to sponsors, investigators, CROs, regulatory affairs, and translation vendors.

Responsibilities

  • Sponsor: Ensures multilingual documents are prepared, validated, and archived per ClinO requirements.
  • Regulatory Affairs (RA): Submits translated documents to BASEC and Swissmedic as required.
  • Principal Investigator (PI): Provides translated subject-facing documents at site and ensures participant comprehension.
  • Translation Vendor: Provides certified translations and back-translations of all essential documents.
  • Quality Assurance (QA): Audits translated materials and ensures retention timelines are respected.

Accountability

The Sponsor’s Head of Clinical Operations is accountable for multilingual documentation compliance and adherence to Swiss retention rules. The PI is accountable for ensuring subjects receive translated materials in appropriate languages (German, French, Italian).

See also  SOP for Managing Regulatory Inspections and Responses

Procedure

1. Translation and Certification

  1. Identify documents requiring translation (ICF, PIS, recruitment materials).
  2. Engage certified translators familiar with medical terminology.
  3. Perform back-translation to confirm accuracy.
  4. File Certificate of Translation Accuracy in TMF (Annexure-1).

2. Submission to BASEC and Swissmedic

  1. Submit multilingual documents as part of initial trial dossier or amendments.
  2. Record acknowledgment in Submission Log.

3. Subject-Facing Documents

  1. Ensure ICFs and PIS are provided in German, French, or Italian depending on trial location.
  2. Confirm participant comprehension during the consent process.

4. Retention of Records

  1. Maintain TMF and ISF records in compliance with Swiss ClinO retention requirements (at least 10 years).
  2. For medical device trials under ClinO-MD, retain records for a minimum of 15 years.
  3. Maintain digital backups of archived records.

5. Quality Control and Auditing

  1. QA team conducts periodic checks of translated materials.
  2. Ensure retention timelines are tracked in Retention Log (Annexure-2).

Abbreviations

  • ClinO: Ordinance on Clinical Trials in Human Research
  • ClinO-MD: Ordinance on Clinical Trials with Medical Devices
  • Swissmedic: Swiss Agency for Therapeutic Products
  • BASEC: Business Administration System for Ethics Committees
  • ICF: Informed Consent Form
  • PIS: Patient Information Sheet
  • PI: Principal Investigator
  • RA: Regulatory Affairs
  • QA: Quality Assurance
  • TMF: Trial Master File
  • ISF: Investigator Site File

Documents

  1. Certificate of Translation Accuracy (Annexure-1)
  2. Retention Log (Annexure-2)
  3. Submission Log (Annexure-3)
See also  SOP for Right-to-Try/Expanded Access Coordination (When Applicable)

References

  • Swissmedic — Clinical Trials
  • Swiss Ethics Committees (BASEC)
  • ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Prepared By Checked By Approved By
Name: Rajesh Kumar
Date: 20/08/2025
Signature: __________
Name: Sunita Reddy
Date: 22/08/2025
Signature: __________
Name: Dr. Meera Iyer
Date: 28/08/2025
Signature: __________

Annexures

Annexure-1: Certificate of Translation Accuracy

Document Translator Date Reviewer
ICF v1.0 French Maria Steiner 05/08/2025 Sunita Reddy

Annexure-2: Retention Log

Protocol No. Record Type Retention Period Archive Location Owner
CH-2025-01 TMF 10 years Zurich Archive Facility Neha Sharma

Annexure-3: Submission Log

Date Protocol No. Document Submitted To Status
12/08/2025 CH-2025-01 French ICF v1.0 BASEC Approved

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
28/08/2025 1.0 Initial SOP for multilingual documentation and country-specific retention rules. New SOP created for Swiss compliance under ClinO/ClinO-MD. Head of Clinical Research

For more SOPs visit: Pharma SOP.

SOP for GCP, Swiss Medic — Unique SOPs Tags:multilingual documentation SOP Switzerland, SOP for archiving Swiss trial documents, SOP for BASEC submission multilingual documents, SOP for bilingual Swiss trial governance, SOP for clinical trial document translation QA, SOP for clinical trial translation Switzerland, SOP for document archival retention Switzerland, SOP for document authenticity Switzerland, SOP for document governance Switzerland, SOP for document localization Switzerland, SOP for ethics submission multilingual Switzerland, SOP for GCP compliance Switzerland, SOP for inspection readiness Switzerland, SOP for ISF retention Switzerland, SOP for language compliance Swiss clinical trials, SOP for multilingual ICFs Switzerland, SOP for patient document translation Switzerland, SOP for record keeping SOP Switzerland, SOP for regulatory submissions multilingual Switzerland, SOP for retention ClinO Switzerland, SOP for sponsor responsibilities Swiss documentation, SOP for sponsor-site responsibilities Switzerland, SOP for TMF retention Switzerland, SOP for translation vendor management Switzerland, Swiss trial document retention SOP

Post navigation

Previous Post: Randomization and Blinding Failures Identified in Inspections
Next Post: SOP for Source Documentation Standards (ALCOA/ALCOA+)

Quick Guide – 1

  • Clinical Trial Phases (7)
    • Preclinical Studies (25)
    • Phase 0 (Microdosing Studies) (6)
    • Phase 1 (Safety and Dosage) (66)
    • Phase 2 (Efficacy and Side Effects) (54)
    • Phase 3 (Confirmation and Monitoring) (70)
    • Phase 4 (Post-Marketing Surveillance) (79)
  • Regulatory Guidelines (71)
    • U.S. FDA Regulations (14)
    • CDSCO (India) Guidelines (11)
    • EMA (European Medicines Agency) Guidelines (17)
    • PMDA (Japan) Guidelines (1)
    • MHRA (UK) Guidelines (1)
    • TGA (Australia) Guidelines (1)
    • Health Canada Guidelines (1)
    • WHO Guidelines (1)
    • ICH Guidelines (12)
    • ASEAN Guidelines (11)
  • Country-Specific Clinical Trials (254)
    • Clinical Trials in USA (51)
    • Clinical Trials in China (49)
    • Clinical Trials in EU (51)
    • Clinical Trials in India (51)
    • Clinical Trials in UK (51)
    • Clinical Trials in Canada (1)
  • Clinical Trial Design and Protocol Development (106)
    • Randomized Controlled Trials (RCTs) (11)
    • Adaptive Trial Designs (10)
    • Crossover Trials (10)
    • Parallel Group Designs (11)
    • Factorial Designs (11)
    • Cluster Randomized Trials (11)
    • Single-Arm Trials (10)
    • Open-Label Studies (11)
    • Blinded Studies (Single, Double, Triple) (11)
    • Non-Inferiority and Equivalence Trials (8)
    • Randomization Techniques in Crossover Trials (1)
  • Good Clinical Practice (GCP) and Compliance (78)
    • GCP Training Programs (11)
    • ICH-GCP Compliance (11)
    • GCP Violations and Audit Responses (11)
    • Monitoring Plans (11)
    • Investigator Responsibilities (11)
    • Sponsor Responsibilities (11)
    • Ethics Committee Roles (11)
  • Clinical Research Operations (44)
    • Study Start-Up Activities (9)
    • Site Selection and Initiation (10)
    • Patient Enrollment Strategies (13)
    • Data Collection and Management (10)
    • Monitoring and Auditing (1)
    • Study Close-Out Procedures (0)
  • Site Management and Monitoring (72)
    • Site Feasibility Assessments (20)
    • Site Initiation Visits (10)
    • Routine Monitoring Visits (10)
    • Source Data Verification (12)
    • Site Close-Out Visits (10)
    • Site Performance Metrics (10)
  • Contract Research Organizations (CROs) (55)
    • Full-Service CROs (11)
    • Functional Service Providers (FSPs) (10)
    • Niche/Specialty CROs (11)
    • CRO Selection Criteria (11)
    • CRO Oversight and Management (11)
  • Patient Recruitment and Retention (57)
    • Recruitment Strategies (11)
    • Retention Strategies (11)
    • Patient Engagement Tools (11)
    • Diversity and Inclusion in Trials (11)
    • Use of Social Media for Recruitment (12)
  • Informed Consent and Ethics Committees (54)
    • Informed Consent Process (11)
    • Ethics Committee Submissions (10)
    • Ethical Considerations in Vulnerable Populations (11)
    • Consent in Emergency Research (10)
    • Re-Consent Procedures (11)
  • Decentralized Clinical Trials (DCTs) (55)
    • Remote Patient Monitoring (10)
    • Telemedicine in Trials (11)
    • Home Health Visits (11)
    • Direct-to-Patient Drug Delivery (11)
    • Digital Consent Platforms (11)
  • Clinical Trial Supply and Logistics (55)
    • Investigational Product Management (11)
    • Cold Chain Logistics (10)
    • Supply Chain Risk Management (11)
    • Labeling and Packaging (11)
    • Return and Destruction of Supplies (11)
  • Safety Reporting and Pharmacovigilance (56)
    • Adverse Event Reporting (11)
    • Serious Adverse Event (SAE) Management (11)
    • Safety Signal Detection (11)
    • Risk Management Plans (11)
    • Periodic Safety Update Reports (PSURs) (11)
  • Clinical Data Management (57)
    • Case Report Form (CRF) Design (11)
    • Data Entry and Validation (11)
    • Query Management (11)
    • Database Lock Procedures (11)
    • Data Archiving (12)
  • Biostatistics in Clinical Research (57)
    • Statistical Analysis Plans (11)
    • Sample Size Determination (11)
    • Interim Analysis (11)
    • Survival Analysis (12)
    • Handling Missing Data (11)
  • Real-World Evidence (RWE) and Observational Studies (56)
    • Registry Studies (11)
    • Retrospective Chart Reviews (11)
    • Prospective Cohort Studies (11)
    • Case-Control Studies (11)
    • Use of Electronic Health Records (EHRs) (11)
  • Medical Writing and Study Documentation (58)
    • Protocol Writing (11)
    • Investigator Brochures (11)
    • Clinical Study Reports (CSRs) (11)
    • Manuscript Preparation (11)
    • Regulatory Submission Documents (13)
  • Trial Master File (TMF) Management (57)
    • TMF Structure and Contents (10)
    • Electronic TMF Systems (7)
    • TMF Quality Control (12)
    • Inspection Readiness (12)
    • Archiving Requirements (11)
  • Protocol Amendments and Version Control (45)
    • Amendment Classification (11)
    • Regulatory Submissions of Amendments (11)
    • Communication of Changes to Sites (11)
    • Version Control Systems (11)
  • Data Integrity and ALCOA+ Principles (46)
    • Attributable, Legible, Contemporaneous, Original, Accurate (ALCOA) (12)
    • Complete, Consistent, Enduring, and Available (ALCOA+) (10)
    • Data Governance Policies (12)
    • Audit Trails (11)
  • Investigator and Site Training (44)
    • Investigator Meetings (11)
    • Site Staff Training Programs (11)
    • Training Documentation (11)
    • Continuing Education Requirements (10)
  • Budgeting and Financial Management (40)
    • Budget Development (10)
    • Site Payment Management (10)
    • Financial Forecasting (10)
    • Cost Tracking and Reporting (10)
  • AI, Big Data, and Technology in Clinical Trials (41)
    • AI in Patient Recruitment (10)
    • Machine Learning for Data Analysis (10)
    • Blockchain for Data Security (10)
    • Wearable Devices and Sensors (11)
  • Career in Clinical Research (52)
    • Clinical Research Coordinator (CRC) Roles (11)
    • Clinical Research Associate (CRA) Roles (10)
    • Data Manager Careers (10)
    • Biostatistician Roles (10)
    • Regulatory Affairs Careers (11)
  • Clinical Trial Registries and Result Disclosure (40)
    • ClinicalTrials.gov Registration (9)
    • EudraCT Registration (10)
    • Results Posting Requirements (10)
    • Transparency Initiatives (11)

Quick Guide – 2

  • Clinical Trial Operations & Data Integrity (31)
    • TMF & eTMF (10)
    • Study Operations & Enrollment (10)
    • Biostats, CDISC & Traceability (11)
  • Clinical Trial Operations & Compliance (54)
    • Clinical Trial Logistics (30)
    • TMF / eTMF Management (6)
    • Clinical Trial Phases & Design (6)
    • Regulatory Submissions (CTD/eCTD) (6)
    • Vendor Oversight & CRO Compliance (6)
  • Quality Assurance and Audit Management (40)
    • Internal Audits (10)
    • External Audits (10)
    • Audit Preparation (10)
    • Corrective and Preventive Actions (CAPA) (10)
  • Risk-Based Monitoring (RBM) (40)
    • Risk Assessment Tools (10)
    • Centralized Monitoring Techniques (10)
    • Key Risk Indicators (KRIs) (10)
    • Key Risk Indicators (KRIs) (10)
  • Standard Operating Procedures (SOPs) (39)
    • SOP Development (9)
    • SOP Training (10)
    • SOP Compliance Monitoring (10)
    • SOP Revision Processes (10)
  • Electronic Data Capture (EDC) and eCRFs (40)
    • EDC System Selection (10)
    • eCRF Design (10)
    • Data Validation Rules (10)
    • User Access Management (10)
  • Wearables and Digital Endpoints (35)
    • Integration of Wearable Devices (10)
    • Digital Biomarkers (9)
    • Data Collection and Analysis (7)
    • Regulatory Considerations (9)
  • Blockchain and Data Security in Trials (39)
    • Blockchain Applications in Clinical Research (10)
    • Data Encryption Methods (9)
    • Access Control Mechanisms (11)
    • Compliance with Data Protection Regulations (9)
  • Biomarkers and Companion Diagnostics (39)
    • Biomarker Identification (10)
    • Validation Processes (10)
    • Companion Diagnostic Development (9)
    • Regulatory Approval Pathways (10)
  • Pediatric and Geriatric Clinical Trials (55)
    • Ethical Considerations (11)
    • Age-Specific Protocol Design (22)
    • Dosing and Safety Assessments (11)
    • Recruitment Strategies (11)
  • Oncology Clinical Trials (54)
    • Phase-Specific Oncology Trials (10)
    • Immunotherapy Studies (14)
    • Biomarker-Driven Trials (10)
    • Basket and Umbrella Trials (8)
    • Cancer Vaccines (12)
  • Vaccine Clinical Trials (40)
    • Phase I–IV Vaccine Trials (10)
    • Immunogenicity Assessments (10)
    • Cold Chain Requirements (10)
    • Post-Marketing Surveillance (10)
  • Rare and Orphan Disease Trials (186)
    • Patient Recruitment Challenges (31)
    • Regulatory Incentives (10)
    • Adaptive Trial Designs (10)
    • Natural History Studies (10)
    • Regulatory Frameworks (22)
    • Trial Design & Methodology (22)
    • Operational Challenges (21)
    • Ethics & Patient Engagement (20)
    • Data & Technology (20)
    • Case Studies & Breakthroughs (20)
  • Bioavailability and Bioequivalence Studies (BA/BE) (41)
    • Study Design Considerations (11)
    • Analytical Method Validation (10)
    • Statistical Analysis Requirements (10)
    • Regulatory Submission (10)
  • Regulatory Submissions and Approvals (73)
    • IND (Investigational New Drug) Submissions (10)
    • CTA (Clinical Trial Application) (10)
    • NDA/BLA/MAA Filings (10)
    • ANDA for Generics (10)
    • eCTD Submission Process (2)
    • Pre-Submission Meetings (FDA Type A/B/C) (10)
    • Regulatory Query Response Handling (10)
    • Post-Approval Commitments (11)
  • Clinical Trial Transparency and Ethics (60)
    • Trial Disclosure Obligations (10)
    • Result Publication Requirements (10)
    • Ethical Review Standards (10)
    • Open Access Data Sharing (10)
    • Informed Consent Disclosure (10)
    • Ethical Dilemmas in Global Research (10)
  • Protocol Deviation and CAPA Management (50)
    • Major vs Minor Deviations (10)
    • Root Cause Analysis (9)
    • CAPA Documentation (9)
    • Preventive Action Planning (1)
    • Monitoring and Training Based on Deviations (10)
    • Deviation Logs and Tracking Tools (11)
  • Audit Trails and Inspection Readiness (59)
    • TMF and eTMF Audit Trails (10)
    • Audit Trail Reviews in EDC (10)
    • Inspection Preparation Checklists (10)
    • Regulatory Inspection Types (Routine, For-Cause) (10)
    • Responding to Audit Observations (9)
    • Mock Inspections and Readiness Drills (10)
  • Study Feasibility and Site Selection (68)
    • Feasibility Questionnaire Design (10)
    • Site Capability Assessment (11)
    • Historical Performance Review (17)
    • Geographic and Demographic Considerations (10)
    • PI (Principal Investigator) Experience Evaluation (10)
    • Site Activation Planning (10)
  • Outsourcing and Vendor Management (65)
    • Vendor Qualification Process (12)
    • Due Diligence and Risk Assessment (11)
    • Vendor Contract Management (12)
    • KPIs for Vendor Performance (10)
    • Vendor Oversight and Audits (10)
    • Communication and Escalation Plans (10)
  • Remote Monitoring and Virtual Visits (64)
    • Centralized Monitoring Techniques (12)
    • Source Data Review Remotely (12)
    • Virtual Site Visits Protocols (11)
    • eConsent and Remote Data Collection (10)
    • Hybrid Monitoring Models (10)
    • Remote Site Training (9)
  • Laboratory and Sample Management (77)
    • Sample Collection SOPs (10)
    • Sample Labeling and Transport (10)
    • Chain of Custody Documentation (11)
    • Bioanalytical Testing and Storage (15)
    • Central vs Local Labs (11)
    • Laboratory Data Reconciliation (20)
  • Adverse Event Reporting and Management (63)
    • AE vs SAE Differentiation (10)
    • Expedited Reporting Timelines (11)
    • MedDRA Coding of Events (11)
    • AE Data Collection in eCRFs (11)
    • Causality and Severity Assessments (10)
    • Regulatory Reporting Requirements (CIOMS, SUSARs) (10)
  • Interim Analysis and Trial Termination (60)
    • Data Monitoring Committees (DMC) (10)
    • Pre-Specified Stopping Rules (10)
    • Statistical Thresholds for Early Stopping (10)
    • Adaptive Modifications Based on Interim Data (10)
    • Unblinding Protocols (10)
    • Reporting of Early Termination to Regulators (10)

Recent Posts

  • Test
  • Comprehensive Guide to Dental Health Care with Braces
  • Understanding Dental Health Care: Managing Implants Cost Effectively
  • Invisalign Alternatives: Practical Dental Health Care Solutions
  • Practical Guide to Dental Health Care: Managing Braces Effectively

Copyright © 2026 Clinical Research Made Simple.

Powered by PressBook WordPress theme